In Israel, They Want to Revolutionize Modern Medical Imaging

For decades, doctors and surgeons have relied on medical imaging to aid in diagnostic decisions, conduct medical interventions more successfully, and choose treatment courses. Methods such as positron emission tomography (PET) and applications of radiological X-ray imaging, such as computed tomography and MRI, are often used for diagnosing and treating diseases, as well as for analyzing the internal structures of the body.

The field of holography, the science and practice of creating holograms, is a relatively new area of medicine, but it holds promising prospects. The Israeli company RealView Imaging aims to create a new dimension for medical imaging applications with its innovative holographic system for the human body.

“This is the only system in the world designed to provide augmented reality solely for doctors for very specific use cases…”, says Kaufman, the founder of RealView Imaging. “It is a very precise and realistic image obtained by ‘extracting’ the patient’s anatomy from the patient and displaying it in the air.”

“Doctors have the ability to interact with this information – to insert a finger inside, cut a holographic organ, mark it, manipulate the image,” says Kaufman. RealView Imaging collaborates with major medical imaging technology manufacturers to provide them with this revolutionary technology.

Kaufman believes that holography is the best method in science for accurately recreating and displaying three-dimensional objects in the air. Since holograms are not optical illusions but rather optical realities, it is very difficult to distinguish a high-quality reconstructed hologram from the original object.

The new development has significant clinical implications, especially for interventional radiology procedures based on three-dimensional imaging. This will allow doctors to enhance the accuracy and efficiency of procedures and better understand spatial anatomy and collateral vascular networks.

According to RealView, modern augmented reality solutions are often mistakenly considered holograms, not actually utilizing true holography based on logical deductions. Furthermore, current solutions allow users to see and interact with 3D images at a distance without the ability to manipulate them, and sometimes cause real headaches for users due to the convergence and accommodation conflict that arises when the brain receives mismatched signals between the distance of a virtual 3D object and the distance of focus.

RealView already holds 21 registered patents, with another 14 under review. Their technologies have already been demonstrated at international exhibitions. Over the next year, Kaufman hopes to conduct several clinical trials in the USA.